A few key strategic elements are critical to the early-stage biotechnology company’s growth and success. These elements serve as a checklist:

 

 

Current or future strategic interests to life science companies are hinged on orphan drug development and forward leaning technologies. 

 

   

       

Executives should approach AI as an instrument to expand their businesses — creating new products or services, increasing productivity — as much as a tool to cut costs

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • Instagram Social Icon